CS
RGLS

Credit Suisse’s Regulus Therapeutics RGLS Stock Holding History

Credit Suisse’s Portfolio RGLS Stock Details RGLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-132
Closed -$35K – 4016
2016
Q4 		$35K Sell
132
-1,160
-90% -$377K ﹤0.01% 4049
2016
Q3 		$512K Sell
1,292
-69
-5% -$28.4K ﹤0.01% 3402
2016
Q2 		$471K Buy
1,361
+180
+15% +$129K ﹤0.01% 3457
2016
Q1 		$982K Sell
1,181
-14
-1% -$11.1K ﹤0.01% 2739
2015
Q4 		$1.25M Buy
1,195
+74
+7% +$74.2K ﹤0.01% 2638
2015
Q3 		$879K Sell
1,121
-1,043
-48% -$1.07M ﹤0.01% 2925
2015
Q2 		$2.85M Buy
2,164
+703
+48% +$1.13M ﹤0.01% 2253
2015
Q1 		$2.97M Buy
1,461
+226
+18% +$491K ﹤0.01% 2070
2014
Q4 		$2.38M Buy
+1,235
New +$2.2M ﹤0.01% 2403
2014
Q3 		– Sell
-125
Closed -$120K – 4615
2014
Q2 		$120K Sell
125
-24
-16% -$20.6K ﹤0.01% 4504
2014
Q1 		$161K Sell
149
-40
-21% -$44.3K ﹤0.01% 4417
2013
Q4 		$168K Buy
189
+104
+122% +$89.5K ﹤0.01% 4379
2013
Q3 		$96K Buy
85
+1
+1% +$1.18K ﹤0.01% 4113
2013
Q2 		$99K Buy
+84
New +$79.9K ﹤0.01% 4017

Other funds holding RGLS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
SDIC
South Dakota Investment Council Sioux Falls, South Dakota $5.84B AUM 30.42% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $1.06B AUM 52.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Credit Suisse's RGLS Position: Q1 2017 in Review

Credit Suisse sold out of Regulus Therapeutics (RGLS) in Q1 2017, closing a stake of 132 shares — an estimated $35K sold.

Credit Suisse first reported a position in RGLS in Q2 2013 and held it in 14 quarters. The position peaked at $2.97M in Q1 2015. 58 funds tracked by Wall St. Rank hold RGLS as of Q1 2017.

  • Credit Suisse reported no remaining Regulus Therapeutics position as of Q1 2017 after selling out during the quarter.
  • Credit Suisse sold 132 Regulus Therapeutics shares in Q1 2017, an estimated $35K.
  • Credit Suisse first reported a position in Regulus Therapeutics in Q2 2013 and held it in 14 quarters.
  • Credit Suisse's Regulus Therapeutics position peaked at $2.97M in Q1 2015.
  • 58 funds tracked by Wall St. Rank held Regulus Therapeutics as of Q1 2017.

Based on Credit Suisse's 13F filing for Q1 2017, filed 15 May 2017.